Buffett Doubles Down on USG; Teva Expected to Appoint New CEO; Crude by Rail Transportation Comes under Scrutiny
publication date: Jan 2, 2014
Buffett more than doubles stake in wallboard maker USG, generic pharmaceutical giant Teva rumored to find CEO, while concerns about crude-by-rail heighten.
To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.